Skip to Main Content

Paper Details

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.
J Neurooncol
29
2016
Author NameAffiliation
Yazmin OdiaNeurological Institute of New York, Columbia University College of Physicians and Surgeons
Howard A FineNew York-Presbyterian Hospital/Weill Cornell Medical Center
  • 1 - 2

Datasets

Release 1.2